Emergent BioSolutions, Inc. (EBS)
5.915
-0.02
(-0.42%)
USD |
NYSE |
Aug 28, 16:00
5.915
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions 30-Day Average Daily Volume : 1.201M for Aug. 27, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 27, 2026 | 1.201M |
| August 26, 2026 | 1.186M |
| August 25, 2026 | 1.176M |
| August 24, 2026 | 1.171M |
| August 21, 2026 | 1.164M |
| August 20, 2026 | 1.157M |
| August 19, 2026 | 1.128M |
| August 18, 2026 | 1.103M |
| August 17, 2026 | 1.101M |
| August 14, 2026 | 1.098M |
| August 13, 2026 | 1.081M |
| August 12, 2026 | 1.051M |
| August 11, 2026 | 1.018M |
| August 10, 2026 | 983138.0 |
| August 07, 2026 | 909359.0 |
| August 06, 2026 | 837046.2 |
| August 05, 2026 | 724794.5 |
| August 04, 2026 | 728451.1 |
| August 03, 2026 | 764083.4 |
| July 31, 2026 | 823683.9 |
| July 30, 2026 | 840464.8 |
| July 29, 2026 | 885539.5 |
| July 28, 2026 | 889408.3 |
| July 27, 2026 | 886095.9 |
| July 24, 2026 | 887541.9 |
| Date | Value |
|---|---|
| July 23, 2026 | 895088.8 |
| July 22, 2026 | 900329.0 |
| July 21, 2026 | 907518.9 |
| July 20, 2026 | 916210.8 |
| July 17, 2026 | 928087.3 |
| July 16, 2026 | 942681.3 |
| July 15, 2026 | 941199.1 |
| July 14, 2026 | 940885.1 |
| July 13, 2026 | 939306.0 |
| July 10, 2026 | 946146.5 |
| July 09, 2026 | 933327.8 |
| July 08, 2026 | 948022.2 |
| July 07, 2026 | 952651.3 |
| July 06, 2026 | 948625.2 |
| July 02, 2026 | 948749.5 |
| July 01, 2026 | 951950.7 |
| June 30, 2026 | 962223.4 |
| June 29, 2026 | 954812.5 |
| June 26, 2026 | 951601.9 |
| June 25, 2026 | 900118.2 |
| June 24, 2026 | 887956.9 |
| June 23, 2026 | 879350.0 |
| June 22, 2026 | 884142.0 |
| June 18, 2026 | 854038.5 |
| June 17, 2026 | 801901.1 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Exelixis, Inc. | 2.492M |
| Capricor Therapeutics, Inc. | 10.70M |
| ADMA Biologics, Inc. | 2.390M |
| Akebia Therapeutics, Inc. | 5.573M |
| Arcutis Biotherapeutics, Inc. | 1.596M |